throbber
Powder Technology,
`0 Elsevier Sequoia
`
`161 - 167
`14 (1976)
`.%A., Lausanne - Printed in the Netherlands
`
`161
`
`Ordered Mixing in Direct Compression of Tablets
`
`hl. J. CROOKS and R. HO
`Department of Pharmacy. University of Sydney, Sydney. N_S.W_ 2006 (Australia)
`(Received November 27, 1975)
`
`SUM?sIARY
`
`The mixing of 2% sulphaphenazole (mean
`diameter 25 pm) with coarse directly com-
`pressible tablet vehicles has been studied using
`a sampling method and scanning electron mi-
`croscopy. At a certain vehicle particle size,
`sulphaphenazole appears to mix by an ordered
`process. After mixing with a 180 - 250-m
`size
`fraction of a sucrose-based vehicle (Dipac) for
`100 minutes, the standard deviation of sulpha-
`phenazole content of 200-mg samples was
`equivalent to that predicted for a random mix.
`The mix did not appear to segregate during
`mixing or on vibration. Under scanning elec-
`tron microscopy in conjunction with energy
`dispersive analysis of X-rays, sulphaphenazole
`appeared to be distributed quite uniformly on
`the coarse vehicle particles.
`
`INTRODUCTION
`
`The advantages of direct compression of
`tablets over traditional granulation techniques
`[ 1 - 31. In its
`have been well documented
`simplest form the process involves just one
`unit operation, that of mixing of drug and
`vehicle, prior to compression. The technique
`is probably most suitable for microdose tah-
`lets where the drug represents less than 5% of
`the total mix. From a drug dissolution stand-
`point the drug should be present in as fine a
`particle size as possible, whereas to ensure
`flowability the vehicle should be in a coarse
`granular form. This poses a mixing problem.
`Classical random mixing theory states that
`such a system would be difficult to mix.
`Recently, the concept of ordered mixing
`has been introduced [4]. This arose from an
`awareness that many glidants and lubricants
`act by adhering onto larger particles, im-
`
`proving flow [ 5 - 7]_ If by careful selection of
`drug and vehicle particle size a non-segregating
`ordered system could be constructed, direct
`compression could be a useful method of
`presenting small amounts of relatively insolu-
`ble drugs in a homogeneous form. The estra-
`granular position of the drug should ensure
`high dissolution rates.
`In this work the mixing of a fine drug,
`sulphaphenazole, with various size fractions
`of two commercially available direct com-
`pression tablet vehicles was studied- Sulpha-
`phenazole was selected as it has a cohesiveness
`and particle size distribution similar to drugs
`which are used in low dosage, e.g. digoxin,
`steroids.
`
`MATERIALS
`
`AND METHODS
`
`Sulphaphenazole was kindly donated by
`Ciba-Geigy Australia. Using an Alpine air-jet
`sieve, the particle size distribution was found
`to be log-normal. The geometric mean weight
`diameter
`(dpw)
`is 25
`/_un and the geometric
`standard deviation (c~) is 1.50. Celutab is a
`dextrose-maltose vehicle obtained from
`Brown and Dureau. From sieve analysis using
`an Endecott sieve shaker, d,, was estimated
`as 325 ~.rm with a us value of 1.75. Dipac, ob-
`tained from A-mstar Corporation, is a sucrose-
`dextrin vehicle with a d,, of 255 pm and og
`of 1.28. By liquid displacement studies at
`25 “C, particle densities of s-ulphaphenazole,
`Celutab and Dipac were estimated as 1.06,
`1.41 and 1.52 g ml-’ respectively.
`Mixing was carried out in an Erweka stain-
`less steel cube mixer (capacity 8 1) rotating at
`20 rpm. The initial load was 800 g, and at
`various time intervals 20 X 200-mg samples
`were removed using a sample thief. The sam-
`ples were assayed by dissolution in 40 ml of
`
`Cosmo Ex. 2021-p. 1
`Argentum v Cosmo
`IPR2018-00080
`
`

`

`162
`
`0.5% sodium carbonate and absorbance mea-
`surement at 250 nm using a Varian 635 u-v.
`spectrophotometer.
`After 100 minutes some systems were es-
`amined under a JS1M-U3 scanning electron
`microscope
`(JEOL Co. Ltd.) fitted with a
`device for energy dispersive analysis of X-rays
`(EDXX
`- Nuclear-Diodes
`Inc.).
`
`DEGREE OF 3IISEDXESS
`
`In the selection of a miser and the required
`mising time,
`it is necessary to compare a mea-
`sure of the variation of drug content
`in the
`mis (normally
`the standard deviation) with
`various parameters_
`The most common parameter used is the
`standard deviation
`for the fully randomised
`showed that the standard
`mix, o:; _ Lzxey
`[S]
`deviation of a fully randomised
`two-compo-
`nent system of identicd densities and particle
`size was gir-en by
`
`<I c = _Y_Vi,l’
`
`(1)
`where s and y are the proportions of the two
`components
`and N is the number of particles
`in the sample taken_ For a mix of two corlpo-
`nents, N is given by [ 33
`
`(2)
`
`where if’ is the weight of the sample and d,,
`and p are the volume-number mean diameter
`and density respectively of each component.
`The value of uR in a directly compressible
`system where components
`are of differing size
`is probably of limited absolute significance,
`particularly
`if crdered rather than random
`mising occurs_ However,
`it can be of value in
`selection of particle size of drug.
`less than 2%
`Where on is small, representing
`of the mean, the standard deviation of the
`sampiing and anaiyticai procedures
`(us) cannot
`be ignored. Thus the lowest standard deviation
`that could be achieved
`for the idealised system
`as described by Lacey wouId be uz, where
`
`U E = OR + Us
`
`(3)
`A more useful value in the practical situa-
`tion is the standard deviation necessary to
`or
`comply with pharmacopoeial
`specifications
`uA [9] _
`a manufacturer’s
`own specification,
`In this work, a, was estimated
`for 95% of
`
`samples falling within 110% of the mean, x,
`then
`
`+1.96u,
`
`= tO.10~
`
`(4)
`or ux = 0.05x. Thus if the mean drclg content
`of a 200-mg
`sample is 4 mg, (I_~ would be equal
`to 0.20 mg.
`
`RESULTS XSD DISCUSSIOS
`
`Figure 1 shows the change in standard de-
`viation with time of a mix of 2% sulpha-
`phenazole
`in Celutab. Studies were carried
`out with various size fractions of Celutab
`in
`addition
`to the unsifted material- Values of
`included on the ordinate-
`are
`GR~
`OE
`and
`0.4
`As the number of sulphaphenazole
`particles
`per 200-mg
`sample greatly exceeds
`the num-
`ber of Celutab particles, uR is relatively
`inde-
`pendent of Celutab particle size. LMising with
`the unsifted Celutab
`is very poor. After rapid
`initial mixing the system segregates, and after
`30 min the standard deviation of sulpha-
`phenazole content
`is greater than 1 mg. Seg-
`regation also occurs in the 250
`- 355~pm and
`the 355
`- 500-pm Celutab, and to a lesser
`extent with the 180
`- 250~pm
`fraction_ Using
`these size fractions of Celutab
`it was not pos-
`sible to mis within a manufacturer’s
`specifica-
`tion of u_, equal to 0.2 mg in 100 min_
`
`=E
`“3
`
`0
`
`20
`
`40
`
`60
`
`100 Y
`80
`tlme.mins
`
`Fig_ l_ Plot of standard deviation of sulphaphenazole
`content of 20 X 200-mg samples us. time for mixing
`of 2% sulphaphenazole with Celutab - Unsifted, 0;
`180 - 250-pm. 0; 250 - 355pm. A; 355
`- 500~Pm. 0;
`0; 710 - 1000 pm. a_ UR
`500 - ilO+m.
`is the thee-
`retical standard deviation of the fully randomised mix
`neglecting standard deviation of the sampling and ana-
`lytical procedure, US_ UE
`is equal to the sum of UR
`and US_ U,
`is a typical manufacturers mixing specifi-
`cation as given by eqn. (4).
`
`Cosmo Ex. 2021-p. 2
`Argentum v Cosmo
`IPR2018-00080
`
`

`

`However, on increasing the Celutab particle
`size fraction
`to 500
`- 710~flrn mixing
`improves,
`and after 50 min the standard deviation of
`to (Jo _
`sulphaphenazole
`content
`is equivalent
`Further mixing does not occur, but the system
`does not appear to segregate. A similar degree
`of misedness can be achieved after 100 min
`using the 710
`- lOOO-pm Celutab. After mixing,
`this material was vibrated
`in the hopper of a
`Manesty SPl single-punch
`tablet machine
`for
`one hour. The standard deviation of samples
`taken from this material,
`indicated by “V” on
`Fig. 1, suggests that the mix is stable to such
`vibration.
`Mixing of 25-pm sulphaphenazole with 710
`lOOO-pm vehicle particles is undoubtedly
`not
`a random process To further investigate
`the
`system, scanning electron microscopy was
`used. Sulphaphenazole
`particles appear to be
`quite angular. esisting mainly as agglomerates
`(Fig. 2)_ 710
`- iOOO-pm Celutab particles ap-
`pear to consist of 10 - 20 smaller spherical
`particles fused together to form an aggregate,
`which is stable to handling (Fig. 3a). On higher
`magnification
`the surface appears relatively
`porous, with few fines adhering (Fig. 3b). At
`even higher magnification
`the fine structure
`of the Cklutab particle appears porous and
`angular (Fig. 3~).
`After mixing for 100 min with 2% sulpha-
`phenazole,
`the Celutab particle adopts a
`“furry” appearance possibly suggesting the
`presence of adsorbed
`fines (Fig. 4a). At mag-
`nifications corresponding
`to those used in
`
`-
`
`163
`
`(b)
`
`Fig. 2. Scanning electron micrograph of sulphaphenazole
`particles.
`
`Fig. 3. Scanning electron micrographs of a Celutab
`particle (710
`- lOOO+m sieve fraction).
`
`Cosmo Ex. 2021-p. 3
`Argentum v Cosmo
`IPR2018-00080
`
`

`

`164
`
`(a)
`
`(b)
`
`(4
`Fig. 4. Scanning electron micrographs of a 710 - lOOO-pm Celutab particle after mixing for 100 min with 2%
`sulpxphenazole.
`
`Fig. 3(b) and (c), adsorbed particles can be
`visualied (Fig. 4b, c). At 2000X magnification
`such a -particle appears to resemble sulpha-
`phenazoIe (Fig. 4~).
`Using conventional scanning electron micro-
`scopy it is difficult to estimate the number of
`adsorbed sulphaphenazole particles per Celutab
`particle. For this purpose the EDAX system
`x-as used_ 1x1 this mode, the X-rays emitted
`x-hen the electron beam strikes the surface of
`the particle can be analysed to yield informa-
`tion as to the chemical composition of the top
`layer of the sample. The detector is sited ciose
`to the specimen, and energy discrimination
`
`takes place within it. The lower end of the
`range of a solid-state counter detector is 1 keV.
`so elements lighter than sodium will not be
`detected. Thus it is possible to scan Celutab
`particles for sulphur with very little back-
`ground from the vehicle, consisting essentially
`of only hydrogen, carbon, nitrogen and ouy-
`gen. The detector was set to pick up X-rays of
`2807 keV, representing the major peak for
`sulphur.
`Figure 5 is an EDAX photograph of a 710 -
`10OOqn-1 Celutab particle after mixing with 2%
`sulphaphenazoie- The white spots represent
`2.307 keV X-rays and the concentrated areas
`
`Cosmo Ex. 2021-p. 4
`Argentum v Cosmo
`IPR2018-00080
`
`

`

`165
`
`equal to uE. Thus a mix was achieved which
`is the best possible from random mixing theo-
`ry. No segregation can be observed, even after
`vibration for one hour in the single-punch
`tablet machine hopper. Figure 7(a) and (b)
`shows scanning electron micrographs of a
`180 - 250-pm Dipac particle and Fig. S(a) and
`(b) shows a similar particle after mising with
`sulphaphenazole_ Adsorbed drug can be iden-
`tified. Under EDAX of three different Dipac
`particles (Fig. 9), it is easy to count the num-
`ber of bound particles. Within each area
`scanned, there appear to be approximately
`15 sulphaphenazole particles. indicating a
`homogeneous distribution of the drug over
`the surface of the vehicle. This represents 5’i
`
`(a)
`
`Fig. 5. Scanning electron micrograph of the system
`Fig. 4 under EDAX.
`
`in
`
`parti-
`the sulphaphenazole
`represent
`of spots
`l/110
`cles. The area scanned is approximately
`of the surface area of a Celutab particle. From
`consideration of the size distribution of the
`two components, there should be approsi-
`mately 2140 sulphaphenazole particles per
`Celutab particle in the mix. From Fig. 5 there
`25 sulphaphenazole
`appear
`to be approximately
`particles in the area scanned, representing 2750
`particles per Celutab particle. This good agree-
`ment suggests that the majority of sulpha-
`phenazole particles are adsorbed onto the
`vehicle particles rather than free within the mix.
`Figure 6 shows mixing data of 2% sulpha-
`phenazole in Dipac. Again, mixing with un-
`sifted Dipac is poor, but with a 180 - 250-ctm
`fraction the observed standard deviation was
`
`0
`
`20
`
`40
`
`60
`
`100 v
`80
`time.mtns
`
`Fig_ 6. Plot of standard deviation of sulphaphenazole
`content of 20 X 200-mg samples L’s. time for mking
`of 2% sulphaphenazole with Dipac - Unsifted, 0;
`180 - 250qm. A; 250 - 355~j.fm. u; 355 - 500-,um, a_
`
`(b)
`Fig_ 7. Scanning electron micrographs of a Dipac par-
`ticle (180
`- 250-pm sieve fraction)_
`
`Cosmo Ex. 2021-p. 5
`Argentum v Cosmo
`IPR2018-00080
`
`

`

`166
`
`(b)
`Fig. A. Scanning electron micrographs of a 180 - 250-
`&ml Dipx particle after mixing for 100 min with BE
`sulphaphenazoIe_
`
`adsorbed drug particles per Dipac particle, com-
`pared with an espected
`ratio of 42 to 1 from
`their size distributions.
`appears
`Ordered mising of sulphaphenazole
`to occur at 2 lower Dipac particle
`size com-
`pared with Celutab. This may
`‘Je because the
`Dipac particle has a more irregular surface,
`allowing close approach of sulphaphenazole
`a smeller size_ Jones [ ‘71 has suggested that
`giidants may adsorb at surface irregularities on
`coarser particles. With larger Dipac size frac-
`tions, mising appears to be poorer and the
`unsifted widely distributed Dipac has a com-
`posite mhing profile.
`
`at
`
`(C
`rfer
`Fig. 9. Scanning electron micrographs of three dii
`DA
`Dipac particles from the system in Fig. 8 under E
`
`Cosmo Ex. 2021-p. 6
`Argentum v Cosmo
`IPR2018-00080
`
`

`

`readily available for dissolution and absorption
`in the gastro-intestinal
`tract.
`
`REFERENCES
`
`It appears that for an ordered mising system
`to be constructed,
`the vehicle should be close
`to monodispersed-
`In a widely distributed
`vehicle, drug may be bound to certain particles
`and some may be free to mis with the remain-
`ing vehicle particles_ Thus if vehicle particles
`themselves segregate from each other, the drug
`will segregate with the fraction to which
`it is
`adsorbed. So if a sample taken from the mix
`does not adequately
`represent the size distri-
`bution of the vehicle as a whole, the drug
`content will be smaller or greater than the
`required mean.
`The mechanism of adsorption of fine mate-
`rials onto coarser particles
`is not well under-
`stood.
`It was suggested that van der LVaals‘ and
`electrostatic
`forces were involved
`in the strong
`adsorption of fine magnesium oside and spray-
`dried lactose onto
`larger particles
`[ 6]_ Travers
`and White demonstrated
`the adsorption of
`micronised
`sodium bicarbonate on coarse
`[IO] _ They proposed
`sucrose particles
`that
`adsorption occurred at cqstal
`indentations
`and irregularities and that electrostatic
`forces
`were probably
`too weak. Other possible
`forces
`involved are chemisorption,
`surface tension or
`frictional
`forces [ 4]_
`The present work suggests that it should be
`possible to design a directly compressible
`sys-
`tem such that ordered mixing occurs. The
`degree of homogeneity
`attainable should be
`as good or better than that achieved by granu-
`lation, with the advantage that the drug is
`
`Cosmo Ex. 2021-p. 7
`Argentum v Cosmo
`IPR2018-00080
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket